Cellectar Biosciences, Inc. — Director's Dealing 2017

Jun 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2017-05-31

Reporting Person: NEIS JOHN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-31	Stock option (right to buy)	$1.74	A	10000	Acquired	2027-05-31	Common Stock (10000)	Direct

Footnotes

F1: Options vest in equal annual increments over a period of three years from the date of grant.